Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 92

1.

Sertraline for the treatment of depression in Alzheimer disease: genetic influences.

Peters ME, Vaidya V, Drye LT, Rosenberg PB, Martin BK, Porsteinsson AP, Frangakis CE, Mintzer J, Weintraub D, Schneider LS, Rabins PV, Munro CA, Meinert CL, Lyketsos CG, Avramopoulos D; DIADS-2 Research Group.

J Geriatr Psychiatry Neurol. 2011 Dec;24(4):222-8. doi: 10.1177/0891988711422527. Erratum in: J Geriatr Psychiatry Neurol. 2012 Sep;25(3):188. Dimitri, Avramopoulos [corrected to Avramopoulos, Dimitri].

PMID:
22228829
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Sertraline for the treatment of depression in Alzheimer disease.

Rosenberg PB, Drye LT, Martin BK, Frangakis C, Mintzer JE, Weintraub D, Porsteinsson AP, Schneider LS, Rabins PV, Munro CA, Meinert CL, Lyketsos CG; DIADS-2 Research Group.

Am J Geriatr Psychiatry. 2010 Feb;18(2):136-45. doi: 10.1097/JGP.0b013e3181c796eb.

PMID:
20087081
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Do treatment effects vary among differing baseline depression criteria in depression in Alzheimer's disease study ± 2 (DIADS-2)?

Drye LT, Martin BK, Frangakis CE, Meinert CL, Mintzer JE, Munro CA, Porsteinsson AP, Rabins PV, Rosenberg PB, Schneider LS, Weintraub D, Lyketsos CG; DIADS-2 Research Group.

Int J Geriatr Psychiatry. 2011 Jun;26(6):573-83. doi: 10.1002/gps.2565.

PMID:
20672243
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Sertraline for the treatment of depression in Alzheimer disease: week-24 outcomes.

Weintraub D, Rosenberg PB, Drye LT, Martin BK, Frangakis C, Mintzer JE, Porsteinsson AP, Schneider LS, Rabins PV, Munro CA, Meinert CL, Lyketsos CG; DIADS-2 Research Group.

Am J Geriatr Psychiatry. 2010 Apr;18(4):332-40. doi: 10.1097/JGP.0b013e3181cc0333.

PMID:
20220589
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Treating depression in Alzheimer disease: efficacy and safety of sertraline therapy, and the benefits of depression reduction: the DIADS.

Lyketsos CG, DelCampo L, Steinberg M, Miles Q, Steele CD, Munro C, Baker AS, Sheppard JM, Frangakis C, Brandt J, Rabins PV.

Arch Gen Psychiatry. 2003 Jul;60(7):737-46.

PMID:
12860778
[PubMed - indexed for MEDLINE]
6.

Randomized, placebo-controlled, double-blind clinical trial of sertraline in the treatment of depression complicating Alzheimer's disease: initial results from the Depression in Alzheimer's Disease study.

Lyketsos CG, Sheppard JM, Steele CD, Kopunek S, Steinberg M, Baker AS, Brandt J, Rabins PV.

Am J Psychiatry. 2000 Oct;157(10):1686-9.

PMID:
11007727
[PubMed - indexed for MEDLINE]
7.

Cognitive response to pharmacological treatment for depression in Alzheimer disease: secondary outcomes from the depression in Alzheimer's disease study (DIADS).

Munro CA, Brandt J, Sheppard JM, Steele CD, Samus QM, Steinberg M, Rabins PV, Lyketsos CG.

Am J Geriatr Psychiatry. 2004 Sep-Oct;12(5):491-8.

PMID:
15353387
[PubMed - indexed for MEDLINE]
8.

Design of Depression in Alzheimer's Disease Study-2.

Martin BK, Frangakis CE, Rosenberg PB, Mintzer JE, Katz IR, Porsteinsson AP, Schneider LS, Rabins PV, Munro CA, Meinert CL, Niederehe G, Lyketsos CG.

Am J Geriatr Psychiatry. 2006 Nov;14(11):920-30.

PMID:
17068314
[PubMed - indexed for MEDLINE]
9.

Comparison of three rating scales as outcome measures for treatment trials of depression in Alzheimer disease: findings from DIADS.

Mayer LS, Bay RC, Politis A, Steinberg M, Steele C, Baker AS, Rabins PV, Lyketsos CG.

Int J Geriatr Psychiatry. 2006 Oct;21(10):930-6.

PMID:
16955427
[PubMed - indexed for MEDLINE]
10.

5-HTTLPR polymorphism of serotonin transporter and effects of sertraline in terminally ill cancer patients: report of eleven cases.

Schillani G, Capozzo MA, Aguglia E, De Vanna M, Grassi L, Conte MA, Giraldi T.

Tumori. 2008 Jul-Aug;94(4):563-7.

PMID:
18822694
[PubMed - indexed for MEDLINE]
11.

Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial.

Banerjee S, Hellier J, Dewey M, Romeo R, Ballard C, Baldwin R, Bentham P, Fox C, Holmes C, Katona C, Knapp M, Lawton C, Lindesay J, Livingston G, McCrae N, Moniz-Cook E, Murray J, Nurock S, Orrell M, O'Brien J, Poppe M, Thomas A, Walwyn R, Wilson K, Burns A.

Lancet. 2011 Jul 30;378(9789):403-11. doi: 10.1016/S0140-6736(11)60830-1. Epub 2011 Jul 19. Review.

PMID:
21764118
[PubMed - indexed for MEDLINE]
12.

Predictive factors for responding to sertraline treatment: views from plasma catecholamine metabolites and serotonin transporter polymorphism.

Umene-Nakano W, Yoshimura R, Ueda N, Suzuki A, Ikenouchi-Sugita A, Hori H, Otani K, Nakamura J.

J Psychopharmacol. 2010 Dec;24(12):1764-71. doi: 10.1177/0269881109106899. Epub 2009 Oct 13.

PMID:
19825907
[PubMed - indexed for MEDLINE]
13.

A randomized, placebo-controlled study of the efficacy and safety of sertraline in the treatment of the behavioral manifestations of Alzheimer's disease in outpatients treated with donepezil.

Finkel SI, Mintzer JE, Dysken M, Krishnan KR, Burt T, McRae T.

Int J Geriatr Psychiatry. 2004 Jan;19(1):9-18.

PMID:
14716694
[PubMed - indexed for MEDLINE]
14.

Sertraline versus fluoxetine in the treatment of major depression: a combined analysis of five double-blind comparator studies.

Feiger AD, Flament MF, Boyer P, Gillespie JA.

Int Clin Psychopharmacol. 2003 Jul;18(4):203-10.

PMID:
12817154
[PubMed - indexed for MEDLINE]
15.

Placebo-controlled study of sertraline in depressed recently abstinent alcoholics.

Roy A.

Biol Psychiatry. 1998 Oct 1;44(7):633-7.

PMID:
9787889
[PubMed - indexed for MEDLINE]
16.

A double-blind, placebo-controlled trial of sertraline for depressive symptoms in patients with stable, chronic schizophrenia.

Mulholland C, Lynch G, King DJ, Cooper SJ.

J Psychopharmacol. 2003 Mar;17(1):107-12.

PMID:
12680747
[PubMed - indexed for MEDLINE]
17.

Genetic polymorphisms in the treatment of depression: speculations from an augmentation study using atomoxetine.

Reimherr F, Amsterdam J, Dunner D, Adler L, Zhang S, Williams D, Marchant B, Michelson D, Nierenberg A, Schatzberg A, Feldman P.

Psychiatry Res. 2010 Jan 30;175(1-2):67-73. doi: 10.1016/j.psychres.2009.01.005. Epub 2009 Dec 6.

PMID:
19969374
[PubMed - indexed for MEDLINE]
18.

Combined treatment with sertraline and liothyronine in major depression: a randomized, double-blind, placebo-controlled trial.

Cooper-Kazaz R, Apter JT, Cohen R, Karagichev L, Muhammed-Moussa S, Grupper D, Drori T, Newman ME, Sackeim HA, Glaser B, Lerer B.

Arch Gen Psychiatry. 2007 Jun;64(6):679-88.

PMID:
17548749
[PubMed - indexed for MEDLINE]
19.

Role of BDNF Val66Met functional polymorphism in Alzheimer's disease-related depression.

Borroni B, Archetti S, Costanzi C, Grassi M, Ferrari M, Radeghieri A, Caimi L, Caltagirone C, Di Luca M, Padovani A; ITINAD Working Group.

Neurobiol Aging. 2009 Sep;30(9):1406-12. doi: 10.1016/j.neurobiolaging.2007.11.023. Epub 2008 Jan 7.

PMID:
18179845
[PubMed - indexed for MEDLINE]
20.

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk